Quantum Healthcare Ltd. (SG:V8Y)
SGX:V8Y
Top Page
Quantum Healthcare Ltd.
(SGX:V8Y)
Select Model
Select Model
Rating:47Neutral
Price Target:―
Action:ReiteratedDate:12/30/25
The score is primarily held back by elevated balance-sheet risk (negative equity and meaningful debt) despite clear operational improvement (strong revenue growth, stable gross margins, narrowing losses, and positive 2024 operating/free cash flow). Limited technical and valuation data prevents confirming momentum or pricing attractiveness, keeping the overall score in the mid range.
Positive Factors
Revenue Growth
The significant revenue growth indicates strong market demand and successful product adoption, which can lead to improved market position and long-term profitability.
Negative Factors
Negative Equity
Negative equity poses a risk to financial stability and limits the company's ability to secure additional financing, impacting long-term growth potential.
Read all positive and negative factors
Positive Factors
Negative Factors
Revenue Growth
The significant revenue growth indicates strong market demand and successful product adoption, which can lead to improved market position and long-term profitability.
Read all positive factors
Quantum Healthcare Ltd. (V8Y) vs. iShares MSCI Singapore ETF (EWS)
Market Cap
S$12.59M
Dividend YieldN/A
Average Volume (3M)N/A
Price to Earnings (P/E)―
Beta (1Y)-4.06
Revenue GrowthN/A
EPS GrowthN/A
CountrySG
Employees87
SectorHealthcare
Sector Strength45
IndustryMedical - Devices
Share Statistics
EPS (TTM)0.00
Shares Outstanding12,587,903,000
10 Day Avg. VolumeN/A
30 Day Avg. VolumeN/A
Financial Highlights & Ratios
PEG Ratio0.18
Price to Book (P/B)-4.40
Price to Sales (P/S)1.25
P/FCF Ratio14.51
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Quantum Healthcare Ltd. Business Overview & Revenue Model
Company Description
Quantum Healthcare Limited, together with its subsidiaries, engages in the design, assembly, and distribution of advanced therapeutic solutions for the minimally invasive treatment of complex vascular diseases in Singapore. It operates through Vas...
How the Company Makes Money
Quantum Healthcare Ltd. generates revenue through multiple streams, primarily by selling its proprietary medical devices and software solutions to healthcare institutions, including hospitals and outpatient clinics. The company also offers subscri...
Quantum Healthcare Ltd. Financial Statement Overview
Summary
Income Statement
36
Negative
Balance Sheet
18
Very Negative
Cash Flow
54
Neutral
| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 12.94M | 12.69M | 13.08M | 9.37M | 0.00 |
| Gross Profit | 5.87M | 5.66M | 5.76M | 4.35M | -246.00K |
| EBITDA | 249.00K | -318.00K | -1.45M | -7.23M | -5.03M |
| Net Income | -1.83M | -2.23M | -3.62M | -9.07M | -5.28M |
Balance Sheet | |||||
| Total Assets | 11.55M | 12.53M | 13.03M | 14.45M | 916.00K |
| Cash, Cash Equivalents and Short-Term Investments | 199.00K | 386.00K | 744.00K | 5.07M | 344.00K |
| Total Debt | 6.86M | 7.64M | 6.51M | 7.55M | 997.00K |
| Total Liabilities | 14.93M | 15.50M | 16.06M | 15.35M | 3.55M |
| Stockholders Equity | -3.96M | -3.62M | -3.87M | -1.50M | -2.59M |
Cash Flow | |||||
| Free Cash Flow | 1.12M | 1.09M | -926.00K | -2.23M | -1.30M |
| Operating Cash Flow | 1.40M | 1.45M | -628.00K | -1.30M | -1.30M |
| Investing Cash Flow | 387.00K | -1.07M | -3.42M | -5.04M | 81.00K |
| Financing Cash Flow | -1.88M | -733.00K | -272.00K | 11.06M | 240.00K |
Quantum Healthcare Ltd. Peers Comparison
UnderperformOutperform
Sector (51)
SG:V8Y
Quantum Healthcare Ltd.
―
―
―
SG:AZT
NutryFarm International
0.09
0.00
0.00%
SG:BFT
Lincotrade & Associates Holdings Limited
0.30
0.20
204.12%
Quantum Healthcare Ltd. Corporate Events
Quantum Healthcare Converts Debt and Directors’ Fees Into Equity, Expanding Share Base
Dec 31, 2025
Quantum Healthcare Limited has completed a major balance sheet exercise involving the conversion of debt owed to PW Dental and the capitalisation of accrued directors’ fees into equity. On 31 December 2025, the company allotted and issued a ...
Quantum Healthcare Ltd. Secures SGX-ST Listing Approval for Strategic Share Issuance
Nov 21, 2025
Quantum Healthcare Ltd. has received a listing and quotation notice from the SGX-ST for the proposed placement of new ordinary shares, conversion of debt into shares, and capitalisation of directors’ fees into shares. This development is con...
Quantum Healthcare Delays Share Placement, Extends Completion Date
Oct 20, 2025
Quantum Healthcare Ltd. announced a delay in its proposed placement of new ordinary shares due to incomplete administrative processes and the need for additional due diligence by the placees. The company has entered into a supplemental agreement t...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.